RUNX1T1 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition to the aforementioned Cyto- patient in the AML cohort, gene fusions were detected in two additional Cyto- cases, including an ALL patient with BCR-ABL rearrangements and a CML patient with AML-ETO fusions.